Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA4 | P22459 | 1/20 | 0.38 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.38 |
| ▸ | KCNAB1 | Q14722 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18589278 | 0.87 | KCNA4 (0.34) | KCNA4KCNA1KCNAB1 | |
| SCHEMBL12769174 | 0.85 | EPHX1 (0.41) | KCNA4KCNA1KCNAB1EPHX1 | |
| SCHEMBL22467787 | 0.82 | EPHX1 (0.33) | KCNA4KCNA1KCNAB1EPHX1 | |
| SCHEMBL18919236 | 0.79 | KCNA4 (0.35) | KCNA4KCNA1KCNAB1 | |
| SCHEMBL31659396 | 0.78 | KCNA4 (0.38) | KCNA4KCNA1KCNAB1EPHX1 | |
| SCHEMBL9339560 | 0.76 | — | — | |
| SCHEMBL11912902 | 0.74 | EPHX1 (0.38) | KCNA4KCNA1KCNAB1EPHX1 | |
| SCHEMBL15899256 | 0.73 | — | — | |
| SCHEMBL31399346 | 0.73 | — | — | |
| SCHEMBL10512380 | 0.72 | KCNA4 (0.33) | KCNA4KCNA1KCNAB1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10808003-B2 | Amphipathic molecule based on tandem malonate and use thereof | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2020-10-20 | — | — | US | claimed |
| US-20200048297-A1 | NOVEL AMPHIPATHIC MOLECULE BASED ON TANDEM MALONATE AND USE THEREOF | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2020-02-13 | — | — | US | claimed |
| US-20190169218-A1 | AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2019-06-06 | — | — | US | claimed |
| EP-3023448-B1 | POLYKETONE POLYMERIZATION CATALYST | HYOSUNG CHEMICAL CORP (KR) | 2018-11-14 | — | — | EP | claimed |
| US-20160333036-A1 | POLYKETONE POLYMERIZATION CATALYST | Hyosung Chemical Corporation (KR) | 2016-11-17 | — | — | US | claimed |
| EP-3023448-A1 | POLYKETONE POLYMERIZATION CATALYST | Hyosung Corporation (KR) | 2016-05-25 | — | — | EP | claimed |
| WO-2025023235-A1 | BRANCHED MULTI-HYDROXYL-PROTECTING OLIGOMER, LINKED BODY BONDED THEREWITH, AND BRANCHED MULTI-HYDROXYL OLIGOMER OBTAINED BY DEPROTECTING SAID LINKED BODY | トモイケ バイオ リミテッド | 2025-01-30 | — | — | WO | disclosed |
| CN-119119119-A | Water-soluble polyketone catalyst ligand and synthesis method thereof | 黄河三角洲京博化工研究院有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-114929839-B | Liquid crystal composition, liquid crystal display element and compound | 石家庄诚志永华显示材料有限公司 | 2024-08-09 | — | — | CN | disclosed |
| US-11999892-B2 | Liquid crystal composition, liquid crystal display element and compound | DIC CORPORATION (JP) | 2024-06-04 | — | — | US | disclosed |
| EP-4194434-A1 | POLYURETHANE, METHOD FOR PRODUCING POLYURETHANE, ELECTROCONDUCTIVE PASTE COMPOSITION, ELECTROCONDUCTIVE WIRE, AND METHOD FOR PRODUCING ELECTROCONDUCTIVE WIRE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-06-14 | — | — | EP | disclosed |
| US-20230131540-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY ELEMENT AND COMPOUND | DIC CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230131540-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY ELEMENT AND COMPOUND | DIC CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| US-4665197-A | NITRIC ACID OXIDATION OF 3,3-BIS/HYDROXYMETHYL/AZETIDINE/ | SHELL OIL COMPANY (US) | 1987-05-12 | — | — | US | disclosed |
| US-4591457-A | Arysulphonyl azetidine compounds used as intermediates | SHELL OIL COMPANY (US) | 1986-05-27 | — | — | US | disclosed |
| US-4569795-A | Arylsulphonyl azetidine compounds, their preparation and their use as intermediates | SHELL OIL COMPANY (US) | 1986-02-11 | — | — | US | disclosed |
| EP-0168852-A1 | Azetidine derivatives and their preparation | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1986-01-22 | — | — | EP | disclosed |
| EP-0165636-A1 | Process for preparing azetidine derivatives and intermediates therein | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1985-12-27 | — | — | EP | disclosed |
| US-4183862-A | Polycyclic polyoxyalkylene compounds | THE DOW CHEMICAL COMPANY (US) | 1980-01-15 | — | — | US | disclosed |
| US-4113739-A | Process for preparation of (poly)cyclic polyethers | THE DOW CHEMICAL COMPANY (US) | 1978-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048297-A1 | NOVEL AMPHIPATHIC MOLECULE BASED ON TANDEM MALONATE AND USE THEREOF | MAL2, LNPK, ANXA6 | KCNA4 2699/4885KCNA1 2233/4885KCNAB1 2906/4885 |
| US-20160333036-A1 | POLYKETONE POLYMERIZATION CATALYST | PNKP, PANK1, DMPK | KCNA4 1986/4885KCNA1 1551/4885KCNAB1 2086/4885 |
| US-10808003-B2 | Amphipathic molecule based on tandem malonate and use thereof | MAL2, LNPK, TSPO | KCNA4 2796/4885KCNA1 2169/4885KCNAB1 3024/4885 |
| US-20190169218-A1 | AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF | UGCG, APMAP, GID4 | KCNA4 2205/4885KCNA1 2542/4885KCNAB1 2850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.